Recent advances in the management of cystic fibrosis
- PMID: 24996790
- DOI: 10.1136/archdischild-2013-304400
Recent advances in the management of cystic fibrosis
Abstract
Cystic fibrosis is a disease that still causes a reduced life expectancy. The treatment burden remains high for affected individuals with often a combination of multiple oral and inhaled medications, as well as physiotherapy, required on a daily basis. In this article, we look at an overview of the pathogenesis, how this might lead to treatment options and look at some of the available new therapies, all in the aim of increasing life expectancy and reducing treatment burden.
Keywords: Cystic Fibrosis; Therapeutics.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Similar articles
-
Emerging therapies in cystic fibrosis.Ther Adv Respir Dis. 2010 Jun;4(3):177-85. doi: 10.1177/1753465810371107. Ther Adv Respir Dis. 2010. PMID: 20530065 Review.
-
Cystic fibrosis enters the proteomics scene: new answers to old questions.Proteomics. 2006 Jul;6(14):4084-99. doi: 10.1002/pmic.200600028. Proteomics. 2006. PMID: 16791827 Review.
-
Recent advances in the understanding and treatment of cystic fibrosis.Curr Opin Pulm Med. 1998 May;4(3):130-4. Curr Opin Pulm Med. 1998. PMID: 9675514 Review.
-
Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis.Curr Opin Chem Biol. 2013 Jun;17(3):353-60. doi: 10.1016/j.cbpa.2013.04.020. Epub 2013 May 24. Curr Opin Chem Biol. 2013. PMID: 23711435 Review.
-
Cystic fibrosis: premature degradation of mutant proteins as a molecular disease mechanism.Methods Mol Biol. 2003;232:27-37. doi: 10.1385/1-59259-394-1:27. Methods Mol Biol. 2003. PMID: 12840537 Review. No abstract available.
Cited by
-
Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention.ISME J. 2016 May;10(5):1081-91. doi: 10.1038/ismej.2015.198. Epub 2015 Nov 10. ISME J. 2016. PMID: 26555248 Free PMC article.
-
CFTR and lung homeostasis.Am J Physiol Lung Cell Mol Physiol. 2014 Dec 15;307(12):L917-23. doi: 10.1152/ajplung.00326.2014. Epub 2014 Nov 7. Am J Physiol Lung Cell Mol Physiol. 2014. PMID: 25381027 Free PMC article. Review.
-
Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem.J Bras Pneumol. 2019 May 30;45(3):e20170351. doi: 10.1590/1806-3713/e20170351. J Bras Pneumol. 2019. PMID: 31166553 Free PMC article.
-
Nodular glomerulosclerosis in a patient with cystic fibrosis, but not diabetes mellitus: A paediatric case.Respir Med Case Rep. 2016 Jul 14;19:58-60. doi: 10.1016/j.rmcr.2016.07.005. eCollection 2016. Respir Med Case Rep. 2016. PMID: 27489763 Free PMC article.
-
Neutrophil extracellular traps and interleukin-1β in cystic fibrosis lung disease.Front Immunol. 2025 Jul 28;16:1595994. doi: 10.3389/fimmu.2025.1595994. eCollection 2025. Front Immunol. 2025. PMID: 40791588 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical